Bookmark and Share

Compound Summary for: CID 656629

omapatrilat

Also known as: BMS-186716; AC1LCVB7; Omapatrilat (JAN/USAN/INN); CHEMBL289556; D01970
Molecular Formula: C19H24N2O4S2   Molecular Weight: 408.53486   InChIKey: LVRLSYPNFFBYCZ-VGWMRTNUSA-N
Omapatrilat is an investigational drug that inhibits both neutral endopeptidase (NEP) and angiotensin converting enzyme (ACE). NEP inhibition results in elevated natriuretic peptide levels, promoting natriuresis, diuresis, vasodilation, and reductions in preload and ventricular remodeling. This drug from BMS was not approved by the FDA due to angioedema safety concerns.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Pharmacology
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _